Dr. Jerry Tan is an adjunct professor at the University of Western Ontario and in private practice in Windsor, Ontario. He is the principal investigator at a clinical research site, Windsor Clinical Research Inc. His career has focused on clinical care, research and cosmetic dermatology.
Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan.
Aside from industry grants, Dr. Tan has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.
His research focus includes acne, acne scars, rosacea and psoriasis. Additional interests include outcome measurements and informed shared decision making in dermatology. He has developed 3 patient decision aids – acne, psoriasis and hidradenitis suppurativa – available at www.informed-decisions.org. A rosacea patient decision aid is currently being created.
Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. During his career, Dr. Tan has authored and co-authored more than 100 peer-reviewed publications.
Conflict of Interest statement: Consultant, speaker, advisor, or investigator for Allergan, Bayer, Cipher, Dermira, Galderma, Stiefel/GSK, Obagi, Pierre Fabre, Photocure, Roche, Valeant.